Discover 1,922 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,922
A Five-Year Quality of Life Study for Cancer Patients
for
Cancer
Location: Grapevine TX
Sponsor: Constantine A. Kotsanis
Sex: All
Age: 18+
Code: NCT01539148
Recruiting
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Episode (MDE), Major Depressive Disorder (MDD),
Location: Garland TX, Southlake TX, Cedar Park TX, Webster TX,
Sponsor: Spyre Therapeutics, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07012395
Phase2, Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Dallas TX, Plano TX, Waxahachie TX, Lampasas TX,
Sponsor: Kallyope Inc.
Sex: All
Age: 18+
Code: NCT07674654
Phase3, Recruiting
Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age
for
Catheter-Related Infections
Location: Fort Worth TX, Birmingham AL, Phoenix AZ, Wilmington DE,
Sponsor: CorMedix Therapeutics
Sex: All
Age: 0 - 17
Code: NCT06714864
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
for
Moderate Aortic Valve Stenosis
Location: Plano TX, Austin TX, Houston TX, Tulsa OK,
Sponsor: Kardigan, Inc.
Sex: All
Age: 50+
Code: NCT07001800
Phase2, Phase3, Recruiting
WRAP North America
for
Venous Stenosis, Venous Occlusion
Location: Fort Worth TX, Humble TX, Dothan AL, Lexington KY,
Sponsor: Merit Medical Systems, Inc.
Sex: All
Age: 18+
Code: NCT06807099
Recruiting
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Dallas TX, Oklahoma City OK, Edmond OK, Bryant AR,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07573176
Phase3, Recruiting
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
for
Acute Treatment of Migraine
Location: Dallas TX, Austin TX, Lake Jackson TX, Ridgeland MS,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07609914
Recruiting
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Dallas TX, Plano TX, Waxahachie TX, Lampasas TX,
Sponsor: Kallyope Inc.
Sex: All
Age: 18 - 70+
Code: NCT07645924
Phase3, Recruiting
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Dallas TX, Tucson AZ, Gainesville FL, Jacksonville FL,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 18+
Code: NCT07759128
Phase3, Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for
Multiple Myeloma
Location: Fort Worth TX, Nashville TN, Chattanooga TN, Canton OH,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05714839
Phase1, Phase2, Recruiting
New
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
for
Preventive Treatment of Migraine
Location: Dallas TX, Austin TX, Oklahoma City OK,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07729462
Phase3, Recruiting
A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel
for
Hypogonadism
Location: Flower Mound TX, Houston TX, Victoria TX,
Sponsor: Acerus Pharmaceuticals Corporation
Sex: Male
Age: 18 - 70+
Code: NCT04976595
Recruiting
Sickle Cell Kidney Biorepository
for
Sickle Cell Trait, Sickle Cell Disease (SCD),
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18 - 65
Code: NCT07064174
Recruiting
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
for
Peripheral Artery Disease (PAD)
Location: DeSoto TX, Plano TX, Oklahoma City OK, Shreveport LA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07318610
Phase3, Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight